Raytech Holding Limited Ordinary Shares
Raytech Holding Limited Ordinary Shares (RAY) Stock Competitors & Peer Comparison
See (RAY) competitors and their performances in Stock Market.
Peer Comparison Table: Household & Personal Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RAY | $2.62 | +0.00% | 46.1M | 43.67 | $0.06 | N/A |
| PG | $158.30 | -0.32% | 371.2B | 25.13 | $6.30 | +2.61% |
| UL | $60.43 | -1.00% | 148.3B | 22.55 | $2.68 | +3.22% |
| CL | $87.93 | -0.59% | 71.3B | 24.92 | $3.53 | +2.32% |
| KVUE | $22.84 | +1.51% | 43.9B | 40.82 | $0.56 | +3.61% |
| KMB | $127.38 | -0.29% | 42.3B | 17.35 | $7.34 | +3.90% |
| EL | $90.40 | +4.18% | 32.5B | -37.36 | -$2.42 | +1.91% |
| CHD | $97.23 | -0.05% | 23.9B | 41.72 | $2.33 | +1.19% |
| CLX | $130.81 | -0.46% | 16.1B | 23.49 | $5.57 | +3.73% |
| SGI | $74.72 | +1.14% | 15.6B | 47.87 | $1.56 | +0.40% |
Stock Comparison
RAY vs PG Comparison July 2025
RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAY stands at 46.1M. In comparison, PG has a market cap of 371.2B. Regarding current trading prices, RAY is priced at $2.62, while PG trades at $158.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAY currently has a P/E ratio of 43.67, whereas PG's P/E ratio is 25.13. In terms of profitability, RAY's ROE is +0.16%, compared to PG's ROE of +0.30%. Regarding short-term risk, RAY is more volatile compared to PG. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check PG's competition here
RAY vs UL Comparison July 2025
RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAY stands at 46.1M. In comparison, UL has a market cap of 148.3B. Regarding current trading prices, RAY is priced at $2.62, while UL trades at $60.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAY currently has a P/E ratio of 43.67, whereas UL's P/E ratio is 22.55. In terms of profitability, RAY's ROE is +0.16%, compared to UL's ROE of +0.29%. Regarding short-term risk, RAY is more volatile compared to UL. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check UL's competition here
RAY vs CL Comparison July 2025
RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAY stands at 46.1M. In comparison, CL has a market cap of 71.3B. Regarding current trading prices, RAY is priced at $2.62, while CL trades at $87.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAY currently has a P/E ratio of 43.67, whereas CL's P/E ratio is 24.92. In terms of profitability, RAY's ROE is +0.16%, compared to CL's ROE of +10.23%. Regarding short-term risk, RAY is more volatile compared to CL. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check CL's competition here
RAY vs KVUE Comparison July 2025
RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAY stands at 46.1M. In comparison, KVUE has a market cap of 43.9B. Regarding current trading prices, RAY is priced at $2.62, while KVUE trades at $22.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAY currently has a P/E ratio of 43.67, whereas KVUE's P/E ratio is 40.82. In terms of profitability, RAY's ROE is +0.16%, compared to KVUE's ROE of +0.10%. Regarding short-term risk, RAY is more volatile compared to KVUE. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check KVUE's competition here
RAY vs KMB Comparison July 2025
RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAY stands at 46.1M. In comparison, KMB has a market cap of 42.3B. Regarding current trading prices, RAY is priced at $2.62, while KMB trades at $127.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAY currently has a P/E ratio of 43.67, whereas KMB's P/E ratio is 17.35. In terms of profitability, RAY's ROE is +0.16%, compared to KMB's ROE of +2.26%. Regarding short-term risk, RAY is more volatile compared to KMB. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check KMB's competition here
RAY vs EL Comparison July 2025
RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAY stands at 46.1M. In comparison, EL has a market cap of 32.5B. Regarding current trading prices, RAY is priced at $2.62, while EL trades at $90.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAY currently has a P/E ratio of 43.67, whereas EL's P/E ratio is -37.36. In terms of profitability, RAY's ROE is +0.16%, compared to EL's ROE of -0.18%. Regarding short-term risk, RAY is more volatile compared to EL. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check EL's competition here
RAY vs CHD Comparison July 2025
RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAY stands at 46.1M. In comparison, CHD has a market cap of 23.9B. Regarding current trading prices, RAY is priced at $2.62, while CHD trades at $97.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAY currently has a P/E ratio of 43.67, whereas CHD's P/E ratio is 41.72. In terms of profitability, RAY's ROE is +0.16%, compared to CHD's ROE of +0.18%. Regarding short-term risk, RAY is more volatile compared to CHD. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check CHD's competition here
RAY vs CLX Comparison July 2025
RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAY stands at 46.1M. In comparison, CLX has a market cap of 16.1B. Regarding current trading prices, RAY is priced at $2.62, while CLX trades at $130.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAY currently has a P/E ratio of 43.67, whereas CLX's P/E ratio is 23.49. In terms of profitability, RAY's ROE is +0.16%, compared to CLX's ROE of +7.42%. Regarding short-term risk, RAY is more volatile compared to CLX. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check CLX's competition here
RAY vs SGI Comparison July 2025
RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAY stands at 46.1M. In comparison, SGI has a market cap of 15.6B. Regarding current trading prices, RAY is priced at $2.62, while SGI trades at $74.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAY currently has a P/E ratio of 43.67, whereas SGI's P/E ratio is 47.87. In terms of profitability, RAY's ROE is +0.16%, compared to SGI's ROE of +0.26%. Regarding short-term risk, RAY is more volatile compared to SGI. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check SGI's competition here
RAY vs HIMS Comparison July 2025
RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAY stands at 46.1M. In comparison, HIMS has a market cap of 12.4B. Regarding current trading prices, RAY is priced at $2.62, while HIMS trades at $57.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAY currently has a P/E ratio of 43.67, whereas HIMS's P/E ratio is 84.76. In terms of profitability, RAY's ROE is +0.16%, compared to HIMS's ROE of +0.36%. Regarding short-term risk, RAY is less volatile compared to HIMS. This indicates potentially lower risk in terms of short-term price fluctuations for RAY.Check HIMS's competition here
RAY vs ELF Comparison July 2025
RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAY stands at 46.1M. In comparison, ELF has a market cap of 6.9B. Regarding current trading prices, RAY is priced at $2.62, while ELF trades at $120.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAY currently has a P/E ratio of 43.67, whereas ELF's P/E ratio is 62.93. In terms of profitability, RAY's ROE is +0.16%, compared to ELF's ROE of +0.24%. Regarding short-term risk, RAY is more volatile compared to ELF. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check ELF's competition here
RAY vs NTCO Comparison July 2025
RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAY stands at 46.1M. In comparison, NTCO has a market cap of 4.6B. Regarding current trading prices, RAY is priced at $2.62, while NTCO trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAY currently has a P/E ratio of 43.67, whereas NTCO's P/E ratio is -11.37. In terms of profitability, RAY's ROE is +0.16%, compared to NTCO's ROE of -0.49%. Regarding short-term risk, RAY is more volatile compared to NTCO. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check NTCO's competition here
RAY vs COTY Comparison July 2025
RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAY stands at 46.1M. In comparison, COTY has a market cap of 4.5B. Regarding current trading prices, RAY is priced at $2.62, while COTY trades at $5.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAY currently has a P/E ratio of 43.67, whereas COTY's P/E ratio is -10.88. In terms of profitability, RAY's ROE is +0.16%, compared to COTY's ROE of -0.10%. Regarding short-term risk, RAY is more volatile compared to COTY. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check COTY's competition here
RAY vs IPAR Comparison July 2025
RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAY stands at 46.1M. In comparison, IPAR has a market cap of 3.9B. Regarding current trading prices, RAY is priced at $2.62, while IPAR trades at $121.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAY currently has a P/E ratio of 43.67, whereas IPAR's P/E ratio is 23.41. In terms of profitability, RAY's ROE is +0.16%, compared to IPAR's ROE of +0.31%. Regarding short-term risk, RAY is more volatile compared to IPAR. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check IPAR's competition here
RAY vs NWL Comparison July 2025
RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAY stands at 46.1M. In comparison, NWL has a market cap of 2.6B. Regarding current trading prices, RAY is priced at $2.62, while NWL trades at $6.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAY currently has a P/E ratio of 43.67, whereas NWL's P/E ratio is -10.63. In terms of profitability, RAY's ROE is +0.16%, compared to NWL's ROE of -0.09%. Regarding short-term risk, RAY is more volatile compared to NWL. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check NWL's competition here
RAY vs SPB Comparison July 2025
RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAY stands at 46.1M. In comparison, SPB has a market cap of 1.5B. Regarding current trading prices, RAY is priced at $2.62, while SPB trades at $60.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAY currently has a P/E ratio of 43.67, whereas SPB's P/E ratio is 28.42. In terms of profitability, RAY's ROE is +0.16%, compared to SPB's ROE of +0.03%. Regarding short-term risk, RAY is more volatile compared to SPB. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check SPB's competition here
RAY vs EPC Comparison July 2025
RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAY stands at 46.1M. In comparison, EPC has a market cap of 1.3B. Regarding current trading prices, RAY is priced at $2.62, while EPC trades at $27.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAY currently has a P/E ratio of 43.67, whereas EPC's P/E ratio is 15.79. In terms of profitability, RAY's ROE is +0.16%, compared to EPC's ROE of +0.05%. Regarding short-term risk, RAY is more volatile compared to EPC. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check EPC's competition here
RAY vs HELE Comparison July 2025
RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAY stands at 46.1M. In comparison, HELE has a market cap of 553.5M. Regarding current trading prices, RAY is priced at $2.62, while HELE trades at $24.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAY currently has a P/E ratio of 43.67, whereas HELE's P/E ratio is -1.66. In terms of profitability, RAY's ROE is +0.16%, compared to HELE's ROE of -0.22%. Regarding short-term risk, RAY is more volatile compared to HELE. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check HELE's competition here
RAY vs NUS Comparison July 2025
RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAY stands at 46.1M. In comparison, NUS has a market cap of 432.4M. Regarding current trading prices, RAY is priced at $2.62, while NUS trades at $8.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAY currently has a P/E ratio of 43.67, whereas NUS's P/E ratio is -10.94. In terms of profitability, RAY's ROE is +0.16%, compared to NUS's ROE of -0.06%. Regarding short-term risk, RAY is more volatile compared to NUS. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check NUS's competition here
RAY vs SLSN Comparison July 2025
RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAY stands at 46.1M. In comparison, SLSN has a market cap of 304.2M. Regarding current trading prices, RAY is priced at $2.62, while SLSN trades at $4.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAY currently has a P/E ratio of 43.67, whereas SLSN's P/E ratio is 86.80. In terms of profitability, RAY's ROE is +0.16%, compared to SLSN's ROE of +0.24%. Regarding short-term risk, RAY is less volatile compared to SLSN. This indicates potentially lower risk in terms of short-term price fluctuations for RAY.Check SLSN's competition here
RAY vs SKIN Comparison July 2025
RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAY stands at 46.1M. In comparison, SKIN has a market cap of 225.6M. Regarding current trading prices, RAY is priced at $2.62, while SKIN trades at $1.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAY currently has a P/E ratio of 43.67, whereas SKIN's P/E ratio is -5.26. In terms of profitability, RAY's ROE is +0.16%, compared to SKIN's ROE of -0.68%. Regarding short-term risk, RAY is more volatile compared to SKIN. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check SKIN's competition here
RAY vs EWCZ Comparison July 2025
RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAY stands at 46.1M. In comparison, EWCZ has a market cap of 222.8M. Regarding current trading prices, RAY is priced at $2.62, while EWCZ trades at $5.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAY currently has a P/E ratio of 43.67, whereas EWCZ's P/E ratio is 25.70. In terms of profitability, RAY's ROE is +0.16%, compared to EWCZ's ROE of +0.13%. Regarding short-term risk, RAY is more volatile compared to EWCZ. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check EWCZ's competition here
RAY vs ACU Comparison July 2025
RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAY stands at 46.1M. In comparison, ACU has a market cap of 162.6M. Regarding current trading prices, RAY is priced at $2.62, while ACU trades at $43.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAY currently has a P/E ratio of 43.67, whereas ACU's P/E ratio is 16.82. In terms of profitability, RAY's ROE is +0.16%, compared to ACU's ROE of +0.05%. Regarding short-term risk, RAY is more volatile compared to ACU. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check ACU's competition here
RAY vs DSY Comparison July 2025
RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAY stands at 46.1M. In comparison, DSY has a market cap of 74.8M. Regarding current trading prices, RAY is priced at $2.62, while DSY trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAY currently has a P/E ratio of 43.67, whereas DSY's P/E ratio is 43.67. In terms of profitability, RAY's ROE is +0.16%, compared to DSY's ROE of -0.03%. Regarding short-term risk, RAY is more volatile compared to DSY. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check DSY's competition here
RAY vs GROV Comparison July 2025
RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAY stands at 46.1M. In comparison, GROV has a market cap of 61.1M. Regarding current trading prices, RAY is priced at $2.62, while GROV trades at $1.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAY currently has a P/E ratio of 43.67, whereas GROV's P/E ratio is -1.96. In terms of profitability, RAY's ROE is +0.16%, compared to GROV's ROE of -1.66%. Regarding short-term risk, RAY is more volatile compared to GROV. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check GROV's competition here
RAY vs UG Comparison July 2025
RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAY stands at 46.1M. In comparison, UG has a market cap of 39M. Regarding current trading prices, RAY is priced at $2.62, while UG trades at $8.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAY currently has a P/E ratio of 43.67, whereas UG's P/E ratio is 13.46. In terms of profitability, RAY's ROE is +0.16%, compared to UG's ROE of +0.33%. Regarding short-term risk, RAY is less volatile compared to UG. This indicates potentially lower risk in terms of short-term price fluctuations for RAY.Check UG's competition here
RAY vs PHH Comparison July 2025
RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAY stands at 46.1M. In comparison, PHH has a market cap of 21.8M. Regarding current trading prices, RAY is priced at $2.62, while PHH trades at $0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAY currently has a P/E ratio of 43.67, whereas PHH's P/E ratio is 41.40. In terms of profitability, RAY's ROE is +0.16%, compared to PHH's ROE of +0.38%. Regarding short-term risk, RAY is more volatile compared to PHH. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check PHH's competition here
RAY vs MTEX Comparison July 2025
RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAY stands at 46.1M. In comparison, MTEX has a market cap of 15.4M. Regarding current trading prices, RAY is priced at $2.62, while MTEX trades at $8.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAY currently has a P/E ratio of 43.67, whereas MTEX's P/E ratio is -73.55. In terms of profitability, RAY's ROE is +0.16%, compared to MTEX's ROE of -0.03%. Regarding short-term risk, RAY is more volatile compared to MTEX. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check MTEX's competition here
RAY vs BRSH Comparison July 2025
RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAY stands at 46.1M. In comparison, BRSH has a market cap of 8.7M. Regarding current trading prices, RAY is priced at $2.62, while BRSH trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAY currently has a P/E ratio of 43.67, whereas BRSH's P/E ratio is -0.01. In terms of profitability, RAY's ROE is +0.16%, compared to BRSH's ROE of +1.19%. Regarding short-term risk, RAY is less volatile compared to BRSH. This indicates potentially lower risk in terms of short-term price fluctuations for RAY.Check BRSH's competition here
RAY vs TANH Comparison July 2025
RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAY stands at 46.1M. In comparison, TANH has a market cap of 2.8M. Regarding current trading prices, RAY is priced at $2.62, while TANH trades at $2.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAY currently has a P/E ratio of 43.67, whereas TANH's P/E ratio is -0.01. In terms of profitability, RAY's ROE is +0.16%, compared to TANH's ROE of -0.03%. Regarding short-term risk, RAY is more volatile compared to TANH. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check TANH's competition here
RAY vs TKLF Comparison July 2025
RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAY stands at 46.1M. In comparison, TKLF has a market cap of 1.7M. Regarding current trading prices, RAY is priced at $2.62, while TKLF trades at $3.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAY currently has a P/E ratio of 43.67, whereas TKLF's P/E ratio is 2.46. In terms of profitability, RAY's ROE is +0.16%, compared to TKLF's ROE of +0.11%. Regarding short-term risk, RAY is more volatile compared to TKLF. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check TKLF's competition here
RAY vs BRSHW Comparison July 2025
RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAY stands at 46.1M. In comparison, BRSHW has a market cap of 6.1K. Regarding current trading prices, RAY is priced at $2.62, while BRSHW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAY currently has a P/E ratio of 43.67, whereas BRSHW's P/E ratio is N/A. In terms of profitability, RAY's ROE is +0.16%, compared to BRSHW's ROE of +1.19%. Regarding short-term risk, RAY is less volatile compared to BRSHW. This indicates potentially lower risk in terms of short-term price fluctuations for RAY.Check BRSHW's competition here
RAY vs SUMR Comparison July 2025
RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAY stands at 46.1M. In comparison, SUMR has a market cap of 0. Regarding current trading prices, RAY is priced at $2.62, while SUMR trades at $11.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAY currently has a P/E ratio of 43.67, whereas SUMR's P/E ratio is -3.66. In terms of profitability, RAY's ROE is +0.16%, compared to SUMR's ROE of -0.75%. Regarding short-term risk, RAY is more volatile compared to SUMR. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check SUMR's competition here
RAY vs REV Comparison July 2025
RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RAY stands at 46.1M. In comparison, REV has a market cap of 0. Regarding current trading prices, RAY is priced at $2.62, while REV trades at $3.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RAY currently has a P/E ratio of 43.67, whereas REV's P/E ratio is -1.19. In terms of profitability, RAY's ROE is +0.16%, compared to REV's ROE of +0.89%. Regarding short-term risk, RAY is less volatile compared to REV. This indicates potentially lower risk in terms of short-term price fluctuations for RAY.Check REV's competition here